Thu, July 16, 2009
Wed, July 15, 2009
Tue, July 14, 2009
Mon, July 13, 2009
Fri, July 10, 2009
Thu, July 9, 2009
Wed, July 8, 2009
Tue, July 7, 2009
Mon, July 6, 2009
Fri, July 3, 2009
Thu, July 2, 2009
Wed, July 1, 2009
Tue, June 30, 2009
Mon, June 29, 2009
Fri, June 26, 2009
Thu, June 25, 2009
Wed, June 24, 2009
Tue, June 23, 2009
Mon, June 22, 2009
Sun, June 21, 2009
Fri, June 19, 2009
Thu, June 18, 2009
Wed, June 17, 2009
Tue, June 16, 2009
Mon, June 15, 2009
Fri, June 12, 2009
Thu, June 11, 2009
Wed, June 10, 2009
Tue, June 9, 2009
Mon, June 8, 2009
Sun, June 7, 2009
Fri, June 5, 2009
Thu, June 4, 2009
Wed, June 3, 2009
Tue, June 2, 2009
Mon, June 1, 2009
Sat, May 30, 2009
Fri, May 29, 2009
Thu, May 28, 2009
Wed, May 27, 2009
Tue, May 26, 2009
Mon, May 25, 2009
Fri, May 22, 2009
Thu, May 21, 2009
Wed, May 20, 2009
Tue, May 19, 2009
Mon, May 18, 2009
Fri, May 15, 2009
Thu, May 14, 2009
Wed, May 13, 2009
Tue, May 12, 2009
Mon, May 11, 2009
Fri, May 8, 2009
Thu, May 7, 2009
Thu, April 16, 2009
Wed, April 15, 2009
Tue, April 14, 2009

Galea Life Sciences, Inc.: Galea Life Sciences, Inc. Announces Completion of 2008 Audit


//health-fitness.news-articles.net/content/2009/ .. nces-inc-announces-completion-of-2008-audit.html
Published in Health and Fitness on Monday, June 8th 2009 at 7:53 GMT, Last Modified on 2009-06-08 07:54:11 by Market Wire   Print publication without navigation


ORLANDO, FL--(Marketwire - June 8, 2009) - Galea Life Sciences, Inc., maker of Nutraplete™ therapeutic drink mix and a pioneer in the field of therapeutic nutrition, announces the completion of its financial audit for its fiscal year ended October 31, 2008. The Company intends to file a new Form 10 registration statement with the SEC. The Company expects its Common stock to open trading on the Over The Counter Bulletin Board (OTCBB), if and when it clears SEC comments on the Form 10, and FINRA has accepted the Company's stock for quotation.

About Nutraplete™

Nutraplete Therapeutic Drink Mix is the first therapeutic nutritional dietary supplement created specifically to help people living with HIV/AIDS. This multi-nutritional, therapeutic "functional food" includes pharmaceutical grade supplements that may provide health benefits by addressing common nutritional deficiencies. Nutraplete is available by prescription and currently approved for Medicaid reimbursement in New York State, New Jersey, Connecticut, Illinois, Nevada and Washington State. The company is currently seeking Medicaid approval in California, Florida, Pennsylvania, Maryland, Washington, D.C. and other states. For more information: [ www.nutraplete.com ]

Nutraplete is distributed exclusively in the U.S. by Allion Healthcare, Inc. ([ www.allionhealthcare.com ]) (NASDAQ: [ ALLI ]) under its MOMS Pharmacy trade name. MOMS Pharmacy is a specialty pharmacy that is focused exclusively on providing medications and support services to people living with HIV/AIDS. Visit [ www.momspharmacy.com ].

About Galea Life Sciences, Inc.

Galea Life Sciences, Inc. focuses on the emerging field of advanced nutritional supplements designed to support traditional medical treatments and therapies, and specializes in the formulation, manufacturing, marketing and distribution of innovative dietary supplements that benefit people undergoing medical treatments and therapies. Nutraplete is its introductory product.

Certain statements in this release constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast," "project," "intend," "expect," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (finance or operating) or achievements to differ from future results, performance (financing and operating) or achievements expressed or implied by such forward-looking statements.

Statements herein express management's beliefs and expectations regarding future performance and are forward-looking and involve risks and uncertainties, including, but not limited to, the ability to negotiate outstanding prior debts of acquired companies; properly identify acquisition partners; adequately perform due diligence; manage and integrate acquired businesses; react to quarterly fluctuations in results; raise working capital and secure other financing; respond to competition and rapidly changing technology; deal with market and stock price fluctuations; and other risks.


Publication Contributing Sources

Similar Health and Fitness Publications